• Home
  • About Us
  • Leadership Team
  • news
  • Careers
  • facility
  • Contact Us
  • news
  • Careers
  • facility
  • Contact Us
  • Home
  • About Us
  • Leadership Team
  • CAREERS

You are here

Home » News

News

Therapure Biopharma Inc. Awarded US Government Contract for Development of Anti-Nerve Gas Agent
06/11/2013
Therapure Biopharma Receives BIOTECanada Gold Leaf Award
05/23/2012
Therapure Announces Opening of Custom Biologics Manufacturing Wing
04/20/2012
Therapure Biopharma Inc. Announces a Successful Health Canada Audit
01/10/2012
Antitope, Ltd., Announces Antibody Research Agreement with Therapure Biopharma, Inc.
11/08/2011
Therapure Biopharma Inc. wins The CMO Leadership Award
10/13/2011
Government of Canada invests in better treatment for Hepatitis C
03/25/2011
International Malaria Research Consortium Combines Technologies and Expertise From Two Continents to Tackle Deadly Disease
10/27/2010
Therapure Biopharma Inc.'s Drug Delivery Program Receives Support from The NRC-IRAP
08/26/2010
BioTuesday.ca: Interview with Thomas Wellner, CEO
08/17/2010

Pages

  • « first
  • ‹ previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • next ›
  • last »
  • News

Disclaimer | Privacy Policy | Contact Us | Accessibility
Privacy Policy | HTML Site Map

Vendor/Supplier Purchase Terms and Conditions
Copyright ©2015 Therapure Biopharma Inc.
Therapure Biomanufacturing, Therapure Innovations and Evolve Biologics are divisions of Therapure Biopharma Inc.

EVENTS

more

NEWS

more

awards

more
☒

Therapure CDMO is now a part of Resilience!

The CDMO assets of Therapure Biopharma Inc have been acquired by Resilience Biotechnologies, Inc., a wholly owned Canadian subsidiary of National Resilience, Inc. (Resilience), a U.S. based biopharmaceutical manufacturing and technology company.


We remain committed to supporting you as Resilience Biotechnologies Inc.




For more information about Resilience, please visit: https://resilience.com




MAKING THE FUTURE OF MEDICINE POSSIBLE